Globeflex Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Globeflex Capital’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-47,097	Closed	-$949K	–	463
2018 Q1	$949K	Sell	47,097 -4,261	-8%	-$99.4K	0.2%	186
2017 Q4	$1.03M	Sell	51,358 -2,319	-4%	-$45.6K	0.29%	129
2017 Q3	$1.11M	Hold	53,677	–	–	0.32%	112
2017 Q2	$794K	Buy	+53,677	New	+$895K	0.2%	192
2017 Q1	–	Sell	-27,503	Closed	-$347K	–	592
2016 Q4	$347K	Hold	27,503	–	–	0.09%	304
2016 Q3	$770K	Hold	27,503	–	–	0.19%	196
2016 Q2	$963K	Hold	27,503	–	–	0.26%	145
2016 Q1	$754K	Buy	27,503 +3,298	+14%	+$97.1K	0.2%	175
2015 Q4	$828K	Buy	+24,205	New	+$755K	0.22%	176

Other funds holding DPLO

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Globeflex Capital's DPLO Position: Q2 2018 in Review

Globeflex Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 47,097 shares — an estimated $949K sold.

Globeflex Capital first reported a position in DPLO in Q4 2015 and held it in 9 quarters. The position peaked at $1.11M in Q3 2017. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

Globeflex Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
Globeflex Capital sold 47,097 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $949K.
Globeflex Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 9 quarters.
Globeflex Capital's DIPLOMAT PHARMACY, INC. position peaked at $1.11M in Q3 2017.
206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Globeflex Capital's 13F filing for Q2 2018, filed 10 Aug 2018.